One of the leading life sciences and healthcare clusters in Europe, Oxfordshire is home to numerous national assets and leading companies from within the sector.
The world-leading Oxfordshire life sciences and healthcare sector:
Download and read the Oxfordshire Life Sciences and Healthcare Sector brochure. Learn more about one of Europe’s most- successful Life Sciences clusters with a track record in establishing and attracting world-leading life sciences and healthcare businesses.
- Home to the University of Oxford, Oxfordshire is part of the UK’s ‘Golden Triangle’, forming an area of significant economic growth and expertise in Life Sciences and Health, alongside Cambridge and London
- The cluster of Life Sciences and Healthcare companies in Oxfordshire provides a critical mass that spurs innovation through extensive multidisciplinary collaboration
- National assets include the Rosalind Franklin Research Institute, Diamond Light Source and STFC’s Central Laser Facility at Harwell Campus and the Structural Genomics Consortium
- The Oxfordshire Local Industrial Strategy positions the county as one of the top-three global innovation ecosystems. It highlights Oxfordshire’s world-leading science and technology cluster and its unsurpassed potential to be a pioneer for the UK through its emerging transformative technologies and sectors
- World-leading spinouts from the University of Oxford include; Oxford Nanopore, Immunocore and Adaptimmune. Foreign-owned companies who have expanded or established operations in Oxfordshire recently include; Novo Nordisk, Intuitive Surgical, Abbott Diabetes Care, Intrexon, Evotec, Sysmex, Agilent and Vertex
Life sciences in Oxfordshire - responding to COVID-19:
The response from the county’s life sciences sector to COVID-19 has been immediate – a mass-mobilisation which is witnessing ground-breaking research around vaccines, diagnostics and treatments, all within a unique ecosystem.
With scores of pioneering academic institutions, many hundreds of innovative life sciences companies, unique research facilities such as the Diamond Light Source (the UK’s national synchrotron), and thousands of people employed in the sector, Oxfordshire is leading the international response.
This presentation explores the many ways in which Oxfordshire’s life sciences sector is responding to the pandemic. For instance, development of the University of Oxford’s primary vaccine candidate, ChAdOx1 nCoV-19, has been undertaken in record time. The process of designing the vaccine to starting clinical trials, which usually takes several years, has been reduced to just four months. The human clinical trials have already started, with the potential for results by Autumn.
The life sciences clusters in Oxfordshire, who are all playing a role in the fight against COVID-19, comprise the Oxford University Hospitals NHS Foundation Trust, Oxford Health NHS Foundation Trust, the University of Oxford and Oxford Brookes University, Harwell Science and Innovation Campus (now also a Life Sciences Opportunities Zone), Culham Science Centre, Oxford Science Park, Old Road Campus, Milton Park and Begbroke Science Park
Should you have questions about investment, innovation or collaboration, and wish to be put in touch with any of the organisations or individuals mentioned, please contact Sebastian Johnson.